资讯
The CSIR is exploring a native herb as a biological medicine or phytopharmaceutical, which is already being tested as medicine for dengue for its efficacy to combat COVID-19. CSIR Director General ...
a flagship proprietary product line comprised of both phytopharmaceutical ingredients and pharma flavors. The new product line for the pharmaceutical industry expands the established EFLA® brand ...
This follows the 2016 acquisition of Extrakt Chemie GmbH & Co.KG, in Stadhagen, near Hannover, Germany, and supports the rapid growth of its pure phytopharmaceutical line. (Photo: http ...
A phytopharmaceutical product, Picroliv, developed by the CDRI, has got the nod for phase-III clinical trial for the treatment of fatty liver disease. Lucknow The Council of Scientific and ...
The Drugs Technical Advisory Board (DTAB), which advises the government on the technical matters related to drugs and pharmaceuticals and medical devices sectors, refused to agree with a proposed ...
The CSIR is also exploring Cocculus Hirsutus, a native herb used by tribes in the country, as a biological medicine or phytopharmaceutical, which is already being tested as medicine for dengue for ...
which includes its subsidiaries and/or associate companies has commenced Phase-II clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug for treatment for COVID-19. The company had ...
New Delhi: Indian Council of Medical Research (ICMR) and Emami Healthcare have signed two memoranda of understanding (MoU), one for the development of standardized phytopharmaceutical formulation ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果